BCHE and Mental deterioration: In patients with the greatest atrophy in nucleus basalis, cognitive decline in patients receiving LMTM as monotherapy was significantly less than those receiving LMTM in combination with either cholinesterase inhibitors (p < 0.0001) or memantine (p = 0.0128).